Russell S. Travers

Array ( [id] => 3913632 [patent_doc_number] => 06001871 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Hypoestoxides, derivatives and agonists thereof for use as antiviral agents' [patent_app_type] => 1 [patent_app_number] => 9/007308 [patent_app_country] => US [patent_app_date] => 1998-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 6402 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001871.pdf [firstpage_image] =>[orig_patent_app_number] => 007308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446845 [patent_doc_number] => 06369048 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Methods and compositions for inactivating viruses' [patent_app_type] => B1 [patent_app_number] => 09/005719 [patent_app_country] => US [patent_app_date] => 1998-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7432 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369048.pdf [firstpage_image] =>[orig_patent_app_number] => 09005719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4155139 [patent_doc_number] => 06107276 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent' [patent_app_type] => 1 [patent_app_number] => 8/997463 [patent_app_country] => US [patent_app_date] => 1997-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2920 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107276.pdf [firstpage_image] =>[orig_patent_app_number] => 997463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032860 [patent_doc_number] => 05994409 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds' [patent_app_type] => 1 [patent_app_number] => 8/987550 [patent_app_country] => US [patent_app_date] => 1997-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11351 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994409.pdf [firstpage_image] =>[orig_patent_app_number] => 987550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248286 [patent_doc_number] => 06136814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Aqueous acyclovir product' [patent_app_type] => 1 [patent_app_number] => 8/986424 [patent_app_country] => US [patent_app_date] => 1997-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8912 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136814.pdf [firstpage_image] =>[orig_patent_app_number] => 986424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174372 [patent_doc_number] => 06083919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Materials and methods for treating autoimmune disease' [patent_app_type] => 1 [patent_app_number] => 8/986063 [patent_app_country] => US [patent_app_date] => 1997-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 5826 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083919.pdf [firstpage_image] =>[orig_patent_app_number] => 986063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3977341 [patent_doc_number] => 05905077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-18 [patent_title] => 'Inhibitors of HIV protease useful for the treatment of AIDS' [patent_app_type] => 1 [patent_app_number] => 8/974430 [patent_app_country] => US [patent_app_date] => 1997-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35164 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 412 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/905/05905077.pdf [firstpage_image] =>[orig_patent_app_number] => 974430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045368 [patent_doc_number] => 05912241 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Methods of use of phthalocyanines to inactivate blood borne parasites' [patent_app_type] => 1 [patent_app_number] => 8/971835 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5398 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912241.pdf [firstpage_image] =>[orig_patent_app_number] => 971835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4075526 [patent_doc_number] => 05965618 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Treatment of scar tissue using lipoic acid' [patent_app_type] => 1 [patent_app_number] => 8/971820 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4096 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965618.pdf [firstpage_image] =>[orig_patent_app_number] => 971820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4082942 [patent_doc_number] => 06054489 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Method for the enhancement of lymphocyte activity against tumors' [patent_app_type] => 1 [patent_app_number] => 8/971849 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9797 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054489.pdf [firstpage_image] =>[orig_patent_app_number] => 971849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4052798 [patent_doc_number] => 05932610 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Tumor necrosis factor .alpha. (TNF-.alpha.) inhibiting pharmaceuticals' [patent_app_type] => 1 [patent_app_number] => 8/952660 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7526 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 403 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932610.pdf [firstpage_image] =>[orig_patent_app_number] => 952660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407221 [patent_doc_number] => 06232333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => 1 [patent_app_number] => 8/966495 [patent_app_country] => US [patent_app_date] => 1997-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13318 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232333.pdf [firstpage_image] =>[orig_patent_app_number] => 966495 [rel_patent_id] =>[rel_patent_doc_number] =>)